Literature DB >> 19349471

Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogma.

Sergio Fazio, MacRae F Linton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19349471      PMCID： PMC2682471          DOI： 10.1210/jc.2009-0344

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  20 in total

1.  The failure of torcetrapib: was it the molecule or the mechanism?

Authors:  Alan R Tall; Laurent Yvan-Charvet; Nan Wang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02       Impact factor: 8.311

2.  Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.

Authors:  A Zambon; J E Hokanson; B G Brown; J D Brunzell
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

3.  Identification of scavenger receptor SR-BI as a high density lipoprotein receptor.

Authors:  S Acton; A Rigotti; K T Landschulz; S Xu; H H Hobbs; M Krieger
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

4.  Molecular characterization of human hepatic lipase deficiency. In vitro expression of two naturally occurring mutations.

Authors:  A Durstenfeld; O Ben-Zeev; K Reue; G Stahnke; M H Doolittle
Journal:  Arterioscler Thromb       Date:  1994-03

5.  Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.

Authors:  S Zhong; D S Sharp; J S Grove; C Bruce; K Yano; J D Curb; A R Tall
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

6.  Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women.

Authors:  M C Carr; A F Ayyobi; S J Murdoch; S S Deeb; J D Brunzell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-04-01       Impact factor: 8.311

7.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

8.  Plasma lipoproteins in familial hepatic lipase deficiency.

Authors:  P W Connelly; G F Maguire; M Lee; J A Little
Journal:  Arteriosclerosis       Date:  1990 Jan-Feb

9.  Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.

Authors:  Trine Holm Johannsen; Pia R Kamstrup; Rolf V Andersen; Gorm B Jensen; Henrik Sillesen; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Journal:  J Clin Endocrinol Metab       Date:  2008-12-16       Impact factor: 5.958

10.  Cholesterol ester transfer protein inhibition with torcetrapib leads to an increase in cardiovascular events: an effect that is unlikely to be the result of increases in blood pressure alone.

Authors:  Michael J Bloch; Jan Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-02       Impact factor: 3.738
View more
  4 in total

1.  HDL subfractions and very early CAD: novel findings from untreated patients in a Chinese cohort.

Authors:  Yan Zhang; Cheng-Gang Zhu; Rui-Xia Xu; Sha Li; Xiao-Lin Li; Yuan-Lin Guo; Na-Qiong Wu; Ying Gao; Ping Qing; Chuan-Jue Cui; Jing Sun; Jian-Jun Li
Journal:  Sci Rep       Date:  2016-08-04       Impact factor: 4.379

2.  Antihyperlipidemic screening and plasma uric acid reducing potential of Momordica charantia seeds on Swiss albino mice model.

Authors:  Md Saddam Hussain; Nusrat Jahan; Md Mamun Or Rashid; Mohammad Salim Hossain; Umay Chen; Naimur Rahman
Journal:  Heliyon       Date:  2019-05-17

3.  Exploring the factors that affect blood cholesterol and heart disease risk: is dietary cholesterol as bad for you as history leads us to believe?

Authors:  Mitchell M Kanter; Penny M Kris-Etherton; Maria Luz Fernandez; Kasey C Vickers; David L Katz
Journal:  Adv Nutr       Date:  2012-09-01       Impact factor: 8.701

4.  Large HDL Subfraction But Not HDL-C Is Closely Linked With Risk Factors, Coronary Severity and Outcomes in a Cohort of Nontreated Patients With Stable Coronary Artery Disease: A Prospective Observational Study.

Authors:  Jian-Jun Li; Yan Zhang; Sha Li; Chuan-Jue Cui; Cheng-Gang Zhu; Yuan-Lin Guo; Na-Qiong Wu; Rui-Xia Xu; Geng Liu; Qian Dong; Jing Sun
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.